Skip to main content
Clinical Trials/NCT05878782
NCT05878782
Not yet recruiting
Not Applicable

Occupational Engagement in Alder Adults With Cancer - the Impact of Occupational Therapy (OCEAN-OT): a Multicenter Randomized Controlled Trial

Assistance Publique - Hôpitaux de Paris0 sites232 target enrollmentSeptember 1, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Elderly Patient
Sponsor
Assistance Publique - Hôpitaux de Paris
Enrollment
232
Primary Endpoint
Quality of life (QLQ-C30 questionnaire)
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

The purpose of this randomized controlled superiority trial is to evaluate the impact of occupational therapy assessment and intervention on the quality of life of elderly cancer patients.

Patients will be randomized into 3 parallel, multicenter arms with patient-reported outcome and blinded evaluator.

  • Experimental group A will combine the assessment of occupational problems (MCRO) and an occupational therapy intervention.
  • Experimental group B will have only the MCRO assessment because the occupational problems assessment alone (without intervention) could improve quality of life and occupational performance outcomes, according to the Nielsen, 2019 study
  • Group C will have the usual cancer management care combining specific treatments and supportive care.

Detailed Description

in order to limit the potential grading bias associated with the open-label design, the reassessment at 3 and 6 months will be performed by a different occupational therapist than the one who performed the initial assessment and occupational therapy intervention. For this reason, at least two occupational therapists per geographic area of the centers that include the patients will be included in the project.

Registry
clinicaltrials.gov
Start Date
September 1, 2023
End Date
May 1, 2026
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • ≥ 70 years;
  • Colorectal, breast, prostate or lung cancer;
  • Between 1 and 3 months after the start of cancer treatment depending on the type of treatment (Surgery and/or systemic treatment and/or radiotherapy);
  • For curative purposes;
  • Affiliated to a social security scheme;
  • Living at home;
  • Agreeing to participate in the research and having given a free, informed and signed consent

Exclusion Criteria

  • person caring for a patient meeting the above criteria;
  • Living with the patient;
  • Agreeing to participate in the research and having given free, informed and signed consent

Outcomes

Primary Outcomes

Quality of life (QLQ-C30 questionnaire)

Time Frame: 3 months

Evolution of the EORTC QLQ-C30 role functioning score at 3 months

Similar Trials